Ran Cui

1.2k citations
25 papers · 984 · 1 hit paper · h-index 10

Impact in

Papers in

    • Cancer-related molecular mechanisms research 3
    • Cancer, Hypoxia, and Metabolism 2
    • Pancreatic and Hepatic Oncology Research 4
    • Cancer Immunotherapy and Biomarkers 2

Ran Cui

22 papers receiving 968 citations

Ran Cui's Hit Papers

METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer 2019 · 478 citations
4780+2+4Years since publication100200300400

Peers

Ran Cui
Comparison fields: 5 of 73
  • Cancer Research 231
  • Molecular Medicine 65
  • Molecular Biology 511
  • Drug Discovery 2
  • Oncology 85
Replace Dandan Wang with:
Dandan Wang China
Qiaoxia Zhang China
Weiguo Huang China
Amirabbas Kakavand Iran
Luca Generoso Italy
Marco Giallombardo Belgium
Siying Zhou China
Kristin M. Stadelman United States
Aparna Mitra United States
Ran Cui relative to Dandan Wang China Dandan Wang's profile →
Citations per field
00.5×1.5×2×2.5×
Dandan Wang · 1×
Citations per year

Countries citing papers authored by Ran Cui

Since Specialization
Citations

This map shows the geographic impact of Ran Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Cui more than expected).

Fields of papers citing papers by Ran Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Cui. The network helps show where Ran Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Ran Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ran Cui Line = papers co-authored together Ran Cui links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
Hit paper breakdown →
2019478
2 2018162
3 2016131
4 201937
5 202130
6 202126
7 201825
8 201915
9 201814
10 201611
11 202110
12 20258
13 20207
14 20226
15 20226
16 20194
17 20234
18 20253
19
Expression of CHD5 may serve as an independent biomarker of prognosis in colorectal cancer via immunohistochemical staining.
20182
20 20222

About Ran Cui

Ran Cui is a scholar working on Cancer Research, Oncology, Ophthalmology, Pathology and Forensic Medicine and Molecular Biology, having authored 25 papers that have together received 984 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ocular Oncology and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Nanoplatforms for cancer theranostics (2 papers), Genetic factors in colorectal cancer (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (231 citations), Molecular Medicine (65 citations), Molecular Biology (511 citations), Drug Discovery (2 citations) and Oncology (85 citations). Ran Cui has collaborated with scholars based in China and United States. Frequent co-authors include Ben Yue, Chenlong Song, Linxi Yang, Zizhen Zhang, Gang Zhao, Ming Zhong, Yiwei Wang, Jin-Jin Lin, Xianting Ding and Jiayi Yu. Their work appears in journals such as Journal of Laparoendoscopic & Advanced Surgical Techniques, Molecular Therapy — Nucleic Acids, Frontiers in Oncology, Frontiers in Immunology and Cancer Management and Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact